Skip to content
Tech Trends Hub

Zimbabwe Turns Down ‘One-Sided’ American Healthcare Assistance Agreement Because of Information Apprehensions

Health funding image
The offered American funding was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a significant American health deal valued at $367m (£272m) over five years due to Washington's request for sensitive information.

The decision came to light following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "skewed".

An official spokesperson has since explained that the US was seeking biological samples for research and commercial purposes but was unwilling to guarantee the resulting advantages from future vaccines.

"We must now begin the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.

A medical body in Zimbabwe has appealed for more dialogue to find a deal agreeable to both sides so the country's vital HIV treatment initiative can continue.

Wider Implications

This rejection follows a comparable situation in neighbouring Kenya, where a court blocked a related health funding agreement following legal challenges were raised about the security of citizens' medical information.

Since returning to office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

The agency had overseen aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and accountability.

As per statements, 16 nations in Africa have so far agreed to similar agreements, representing over $18.3bn in committed funds.

Details of the Rejected Deal

The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".

"Our nation was requested to surrender its genetic material and health information indefinitely, with no equivalent promise of access to any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.

"In essence, our country would provide the raw materials for scientific discovery without any assurance that the final treatments would be available to our citizens should a new health crisis arise."

National Interest and International Frameworks

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems previously established via the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential pandemics.

"This framework is designed to ensure that when a nation provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."

These objections regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We are open to continued discussions with our US partners on how future co-operation might be structured in a manner that respects the independence and interests of both nations."

Medical Community Response

Medical experts stated it recognised the official position, but urged that talks should continue since much of the nation's HIV programmes relied on external financing.

"In cases where specific concerns exist, including those involving data governance or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," the group said.

This impasse underscores the complex debate between accepting much-needed international aid and protecting a country's data in an ever more interconnected world.

About the author

Dorothy Wolfe

A software engineer and tech writer passionate about open-source projects and emerging technologies, with over a decade of industry experience.

Tech Trends Hub

Type to search articles.